Literature DB >> 19579071

Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations.

Elizabeth E Uhlenhake1, David Kurkowski, Steven R Feldman.   

Abstract

BACKGROUND: The role of the patient-physician relationship is a key issue in the management of lifelong, chronic conditions such as psoriasis, with each side bringing different perspectives.
OBJECTIVE: To explore areas of congruence and disconnection in the relationship between psoriasis patients and dermatologists, with a focus on communication issues.
METHODS: Three discussion group sessions were held in four centers across the United States with dermatologists, patients, and a follow-up of the dermatologists after watching the patient discussion.
RESULTS: Patients want more information on psoriasis, fast treatments, clear expectations from the onset of therapy, and recognition of the emotional burden. Dermatologists found that patients do not receive or internalize adequate information and need further explanation of treatment regimens to increase compliance and patient satisfaction. LIMITATIONS: This was a qualitative study assessing the range of responses and was not a quantitative study designed to test specific hypotheses. The study may not be informative about the experiences of people with psoriasis not actively seeing a physician.
CONCLUSIONS: Encounters between physicians and psoriasis patients can be enhanced by providing information on what psoriasis is, choosing fast-acting treatments that patients are willing to use, and providing written materials about the disease and treatment plan.

Entities:  

Mesh:

Year:  2010        PMID: 19579071     DOI: 10.3109/09546630903085328

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  8 in total

Review 1.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

2.  Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non-responders: Subgroup analysis of UNCOVER-3 trial.

Authors:  D Rosmarin; S Smith; D Shrom; R Burge; K See; M McKean-Matthews; T Ridenour; C-Y Lin; J Gorelick
Journal:  Skin Health Dis       Date:  2021-05-11

3.  How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey.

Authors:  Anna Graziella Burroni; Mariella Fassino; Antonio Torti; Elena Visentin
Journal:  Patient Relat Outcome Meas       Date:  2015-02-16

4.  Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature.

Authors:  José Antonio Sacristán; Tatiana Dilla; Silvia Díaz-Cerezo; Clara Gabás-Rivera; Susana Aceituno; Luis Lizán
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

Review 5.  Optimal diagnosis and management of common nail disorders.

Authors:  Debra K Lee; Shari R Lipner
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

6.  Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis.

Authors:  Georgios Kokolakis; Kasper Vadstrup; Jes B Hansen; Jose Manuel Carrascosa
Journal:  Dermatology       Date:  2021-11-25       Impact factor: 5.197

7.  'On the surface': a qualitative study of GPs' and patients' perspectives on psoriasis.

Authors:  Pauline A Nelson; Zoë Barker; Christopher E M Griffiths; Lis Cordingley; Carolyn A Chew-Graham
Journal:  BMC Fam Pract       Date:  2013-10-20       Impact factor: 2.497

8.  Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).

Authors:  Kristian Reich; Ulrich Mrowietz; Eleni Karakasili; Ina Zschocke
Journal:  Arch Dermatol Res       Date:  2014-06-04       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.